Down-regulation of miRNA-145 activated TGF-β signaling, followed by enhanced abilities of cell migration and invasion both in vivo and in vitro. The role of miRNA-145 in inhibiting EMT through TGF-β signaling pathway indicated that miRNA-145 could be a potential candidate in anti-cancer drug development. Here, TGFB1 is linked to cancer.